Our registered charity led a collective patient input submission with the Canadian Cancer Survivor Network on pembrolizumab in combination with chemotherapy with or without bevacizumab, for the treatment of adult patients with persistent, recurrent, or metastatic cervical cancer. Our role was to ensure the advanced cervical cancer patient perspective was sought and captured for the therapeutic under review. This was our first patient input submission to CADTH and INESSS and we plan to expand our role in this space contributing to helping more patients with HPV-related cancers.